Point mutations in the Plasmodium falciparum cg2 gene, polymorphism of the kappa repeat region, and their relationship with chloroquine resistance

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 95, Issue 3, 2001, Pages 309-314

  Basco, Leonardo K ^a,c   Ringwald, Pascal ^a,b  

^a Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Institut de Recherche pour le Developpement Cameroon   (Cameroon)

Author keywords

Cameroon; cg2; Chloroquine; Drug resistance; Genetic analysis; Mutations; Plasmodium falciparum

Indexed keywords

ANTIMALARIAL AGENT; CG2 PROTEIN, PLASMODIUM FALCIPARUM; CHLOROQUINE; PROTOZOAL PROTEIN;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALARIA FALCIPARUM; NUCLEOTIDE REPEAT; POINT MUTATION; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL;

ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; POINT MUTATION; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 0035345945     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(01)90247-0     Document Type: Article

References (20)

1. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A. & Struhl, K. (1995). Short Protocols in Molecular Biology, 3rd edn, New York: John Wiley & Sons, Inc.
2. Basco, L. K. & Ringwald, P. (1999a). Chloroquine resistance in Plasmodium falciparum and polymorphism of cg2 gene. Journal of Infectious Diseases, 180, 1979-1986.
3. Basco, L. K. & Ringwald, P. (1999b). Molecular epidemiology of malaria in Yaoundé, Cameroon. V. Analysis of the omega repetitive region of the Plasmodium falciparum cg2 gene and chloroquine resistance. American Journal of Tropical Medicine and Hygiene, 61, 807-813.
4. Basco, L. K. & Ringwald, P. (2001). Molecular epidemiology of malaria in Yaoundé, Cameroon. VII. Analysis of recrudescence and reinfection in patients with uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene, (in press).
5. + antiporter, chloroquine uptake and drug resistance: incon-sistencies in a newly proposed model. Parasitology Today, 15, 360-363.
6. Desjardins, R. E., Canfield, C. J., Haynes, J. D. & Chulay, J. D. (1979). Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrobial Agents and Chemotherapy, 16, 710-718.
7. Durand, R., Gabbett, E., Di Piazza, J. P., Delabre, J. F. & Le Bras, J. (1999). Analysis of kappa and omega repeats of the cg2 gene and chloroquine susceptibility of Plasmodium falciparum from sub-Saharan Africa. Molecular and Biochemical Parasitology, 101, 185-197.
8. Fidock, D. A., Nomura, T., Cooper, R. A., Su, X. Z., Talley, A. K. & Wellems, T. E. (2000). Allelic modifications of the cg2 and cgl genes do not alter the chloroquine response of drugresistant Plasmodium falciparum. Molecular and Biochemical Parasitology, 110, 1-10.
9. Mount, D. L., Nahlen, B. L., Patchen, L. C. & Churchill, F. C. (1989). Adaptations of the Sakar-Solomons test: simple, reliable colorimetric field assays for chloroquine and its metabolites in urine. Bulletin of the World Health Organization, 67, 295-300.
10. Ringwald, P. & Basco, L. K. (1999). Comparison of in vivo and in vitro tests of resistance in patients treated with chloroquine in Yaoundé, Cameroon. Bulletin of the World Health Organization, 77, 34-43.
11. Ringwald, P., Bickii, J. & Basco, L. (1996a). Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Mrica. Lancet, 347, 24-28.
12. Ringwald, P., Bickii, J. & Basco, L. K. (1996b). In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaoundé, Cameroon. American Journal of Tropical Medicine and Hygiene, 55, 254-258.
13. Ringwald, P., Bickii, J. & Basco, L. K. (1998). Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children. Clinical Infections Diseases, 26, 946-953.
14. + exchanger of Plasmodium falciparum? Cell, 92, 601-602.
15. Sirawaraporn, W., Sathitkul, T., Sirawaraporn, R., Yuthavong, Y. & Santi, D. V. (1997). Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proceedings of the National Academy of Sciences of the USA, 94, 1124-1129.
16. Su, X. Z., Kirkman, L. A., Fujioka, H. & Wellems, T. E. (1997). Complex polymorphisms in an ∼330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell, 91, 593-603.
17. Triglia, T., Menting, J. G. T., Wilson, C. & Cowman, A. F. (1997). Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proceedings of the National Academy of Sciences of the USA, 94, 13944-13949.
18. + exchangers. Cell, 94, 285-286.
19. WHO (1990). Severe and complicated malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, supplement 2.
20. WHO (1996). Assessment of therapeutic efficacy for uncomplicated falciparum malaria in areas with intense transmission. Geneva, Switzerland: World Health Organization. WHO/MAL/ 96.1077.